Carregant...
Exploring genetic counselors’ perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM)
Pathogenic germline mutations in the BRCA1 or BRCA2 genes are associated with an elevated lifetime risk for breast (50–85% risk) and ovarian cancer (20–40% risk). Genome-wide association studies have identified over 100 genetic variants associated with modified breast and/or ovarian cancer risk in B...
Guardat en:
| Publicat a: | J Genet Couns |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6548677/ https://ncbi.nlm.nih.gov/pubmed/30843639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgc4.1079 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|